|
财务报告
| Apr 2025 to Mar 2026 | Apr 2024 to Mar 2025 | Growth in % 2026 vs 2025 | |
| Incoming Receipts (S$’000) | |||
| Donations | |||
| – Tax Deductible | 12,155.99 | 9,036.40 | 35% |
| – Non Tax Deductible | 1,086.19 | 477.05 | 128% |
| Grants/Sponsorships | 177.22 | 176.49 | NM |
| Investment Income | 6,297.05 | 6,000.93 | 5% |
| Others | |||
| – Programme Fees | 1,182.75 | 1,033.73 | 14% |
| – Other Income | 186.12 | 83.45 | 123% |
| Total Receipts | 21,085.32 | 16,808.05 | 25% |
| Apr 2025 to Mar 2026 | Apr 2024 to Mar 2025 | Growth in % 2026 vs 2025 | |
| Expenses (S$’000) | |||
| Direct Charitable | 10,654.14 | 8,710.27 | 22% |
| Operating/Administrative | 2,750.95 | 1,703.84 | 61% |
| Fundraising | 2,816.70 | 2,102.31 | 34% |
| Total Expenses | 16,221.80 | 12,516.42 | 30% |
| Net Deficit before Gain from Investments (S $’000) | (1,303.61) | (1,639.32) | -20% |
| Investment Income | 1,660.42 | 1,930.01 | -14% |
| Fair Value Gain on Financial Instruments at FVTPL | 3,576.23 | 3,651.54 | -2% |
| Gain on Disposal of Investments | 940.99 | 349.40 | 169% |
| Net Surplus for the Year | 4,874.03 | 4,291.63 | 14% |
| Apr 2025 to Mar 2026 | Apr 2024 to Mar 2025 | Growth in % 2026 vs 2025 | |
| Balance Sheet (S$’000) | |||
| Assets | |||
| Leasehold Property | 12,883.10 | 13,129.20 | -2% |
| Tangible Assets | 1,287.63 | 1,919.82 | -33% |
| Right-of-Use Assets | 277.54 | 127.70 | 117% |
| Investments | 49,948.83 | 48,957.76 | 2% |
| Other Non-financial Assets | 1,249.60 | – | 100% |
| Inventories | 12.71 | 13.94 | -9% |
| Accounts Receivable | 120.67 | 219.53 | -45% |
| Other Assets | 884.72 | 928.85 | -5% |
| Cash & Deposits | 10,103.66 | 5,952.13 | 70% |
| Total Assets | 76,768.46 | 71,248.93 | 8% |
| Apr 2025 to Mar 2026 | Apr 2024 to Mar 2025 | Growth in % 2026 vs 2025 | |
| Funds (S$’000) | |||
| Unrestricted Funds | |||
| – General Fund | 42,289.88 | 36,548.87 | 16% |
| – Other Reserves | – | 2.25 | -100% |
| – Infrastructure Development Fund | 30,320.91 | 31,187.88 | -3% |
| Total Unrestricted Funds | 72,610.79 | 67,739.00 | 7% |
| Restricted Funds | |||
| – Care & Share Matching Grant | 5.26 | 13.37 | -61% |
| – Edwards Lifesciences Foundation | 102.23 | 104.63 | -2% |
| Total Restricted Funds | 107.49 | 118.00 | -9% |
| Total Funds | 72,718.28 | 67,857.00 | 7% |
| Apr 2025 to Mar 2026 | Apr 2024 to Mar 2025 | Growth in % 2026 vs 2025 | |
| Liabilities (S$’000) | |||
| Long Term Liabilities | 287.74 | 208.24 | 38% |
| Current Liabilities | 3,762.43 | 3,183.69 | 18% |
| Total Liabilities | 4,050.17 | 3,391.93 | 19% |
| Total Liabilities and Funds | 76,768.46 | 71,248.93 | 8% |
| Apr 2025 to Mar 2026 | Apr 2024 to Mar 2025 | Growth in % 2026 vs 2025 | |
| Other Information | |||
| Donations/Grants and Sponsorships Given to Other Registered Charities (S$’000) | 465.69 | 143.94 | 224% |
| Number of Employees | 60 | 56 | 7% |
| Total Employee Cost (S$’000) | 7,736.78 | 6,058.42 | 28% |
| Fund Raising Efficiency Ratio (should not exceed 30%) | 21% | 22% | -5% |
NM = Not Meaningful
